Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer

被引：0
|
作者：
Sheng Zhang
Yongzhi Yang
Wenhao Weng
Bomin Guo
Guoxiang Cai
Yanlei Ma
Sanjun Cai
机构：
[1] Fudan University Shanghai Cancer Center,Department of Colorectal Surgery
[2] Fudan University,Department of Oncology, Shanghai Medical College
[3] Tongji University School of Medicine,Department of Clinical Laboratory, Yangpu Hospital
[4] Tongji University School of Medicine,Center for Translational Medicine, Yangpu Hospital
[5] Shanghai Jiao Tong University Affiliated Sixth People’s Hospital,Department of Surgery
来源：
Journal of Experimental & Clinical Cancer Research | / 38卷
关键词：
BIRC3; 5-fluorouracil; Chemoresistance; Colorectal cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β-catenin modulator Annexin A1
    Rubinstein, Mara Roxana
    Baik, Jung Eun
    Lagana, Stephen M.
    Han, Richard P.
    Raab, William J.
    Sahoo, Debashis
    Dalerba, Piero
    Wang, Timothy C.
    Han, Yiping W.
    EMBO REPORTS, 2019, 20 (04)
  • [32] MicroRNA-375-3p enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer
    Xu, Fei
    Ye, Ming-Liang
    Zhang, Yu-Peng
    Li, Wen-Jie
    Li, Meng-Ting
    Wang, Hai-Zhou
    Qiu, Xiao
    Xu, Yan
    Yin, Jin-Wen
    Hu, Qian
    Wei, Wan-Hui
    Chang, Ying
    Liu, Lan
    Zhao, Qiu
    CANCER SCIENCE, 2020, 111 (05) : 1528 - 1541
  • [33] Chemoresistance mechanisms to 5-Fluorouracil and reversal strategies in lung and breast cancer
    Zhong, Chunge
    Wang, Shengnan
    Jiang, Wen-Jie
    Li, Zexu
    Wang, Xiaofeng
    Fan, Shuangshuang
    Huang, Jun
    Wu, Hua-Jun
    Sheng, Ren
    Fei, Teng
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [34] WNT3 promotes chemoresistance to 5-Fluorouracil in oral squamous cell carcinoma via activating the canonical β-catenin pathway
    Zhang, Xuyang
    Sun, Kairui
    Gan, Ruihuan
    Yan, Yuxiang
    Zhang, Chaochao
    Zheng, Dali
    Lu, Youguang
    BMC CANCER, 2024, 24 (01)
  • [35] Exploring the interplay between Fusobacterium nucleatum with the expression of microRNA, and inflammatory mediators in colorectal cancer
    Bostanghadiri, Narjess
    Razavi, Shabnam
    Shariati, Aref
    Talebi, Malihe
    Mirkalantari, Shiva
    Emami Razavi, Amirnader
    Darban-Sarokhalil, Davood
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [36] Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer
    Toden, Shusuke
    Hanh-My Tran
    Tovar-Camargo, Oscar A.
    Okugawa, Yoshinaga
    Goel, Ajay
    ONCOTARGET, 2016, 7 (13) : 16158 - 16171
  • [37] BIOCHEMICAL MODULATION OF 5-FLUOROURACIL - A RANDOMIZED COMPARISON OF SEQUENTIAL METHOTREXATE, 5-FLUOROURACIL AND LEUCOVORIN VERSUS SEQUENTIAL 5-FLUOROURACIL AND LEUCOVORIN IN PATIENTS WITH ADVANCED SYMPTOMATIC COLORECTAL-CANCER
    GLIMELIUS, B
    ANNALS OF ONCOLOGY, 1993, 4 (03) : 235 - 240
  • [38] Beyond 5-fluorouracil monochemotherapy in colorectal cancer - It is time
    Satta, F
    Franchi, F
    JOURNAL OF CHEMOTHERAPY, 1997, 9 (06) : 431 - 435
  • [39] Bufalin and 5-fluorouracil synergistically induce apoptosis in colorectal cancer cells
    Dai, Xiao-Yu
    Zhou, Bao-Feng
    Xie, Yang-Yang
    Lou, Jie
    Li, Ke-Qiang
    ONCOLOGY LETTERS, 2018, 15 (05) : 8019 - 8026
  • [40] CDK inhibitor enhances the sensitivity to 5-fluorouracil in colorectal cancer cells
    Takagi, Koichi
    Sowa, Yoshihiro
    Cevik, Ozgur Muhammer
    Nakanishi, Ryoko
    Sakai, Toshiyuki
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2008, 32 (05) : 1105 - 1110
12345